OBJECTIVE -The metabolic syndrome is a loosely defined cluster of cardiovascular risk factors including low HDL cholesterol, hypertriglyceridemia, glucose intolerance, and hypertension. Evidence for inclusion of these features in the syndrome has mostly come from crosssectional studies, and a few studies have examined how the various factors change together over time.
T he metabolic syndrome, otherwise known as syndrome X or the insulin resistance syndrome, is a loosely defined clustering of cardiovascular risk factors, including low HDL cholesterol, hypertriglyceridemia, glucose intolerance, and hypertension. Because it predicts both diabetes and cardiovascular diseases (1, 2) , this syndrome is particularly important because it may provide a common pathway linking these two disorders. The variety of alternative names for the condition indicates the uncertainty about the definition of the syndrome and the importance that may be attributed to distinct features such as insulin resistance. Establishing definitions for the syndrome and its component features is an important step in the process of understanding its etiology and pathogenesis.
Previous studies have indicated that the main features of the syndrome cluster together more frequently than would be expected by chance alone (2) , suggesting the existence of a common underlying mechanism, such as insulin resistance (1-3). However, it is possible that the syndrome could center on other abnormalities such as overall or central obesity (4, 5) .
The lack of an accepted and experimentally justified definition makes epidemiological study of this disorder difficult. Attempts at defining it are often implicitly limited by assumptions about its etiology and run the risk of becoming tautological. An alternative approach may be to derive a definition directly from the data without prior hypotheses about how the various factors are linked or which of the factors is central or dominant. Factor analysis provides one possible means of allowing the clustering of variables within a population to be described without prior assumptions about their inter-relationship. This technique has been used previously in cross-sectional studies to identify underlying features of the metabolic syndrome (3, 6, 7) . However, this method has not been used with longitudinal data to investigate how the features of the syndrome change together over time. This may provide stronger information about causal pathways than cross-sectional analysis. The aim of this study was to describe the inter-relationship of the features of the metabolic syndrome over time using longitudinal factor analysis.
RESEARCH DESIGN AND METHODS -The
Ely study is a prospective population-based cohort established in 1990, which has previously been described in detail (8) . Subjects for the study were recruited from a general practice register in Ely Cambridgeshire. A letter of invitation was sent to a random selection of 1,571 patients not previously known to have diabetes, between the ages of 40 and 65 years at recruitment, and 1,122 were screened. A total of 1,071 sub-
jects who participated in the first phase of the study (1990 -1992) were found to have either normal or impaired glucose tolerance in a 75-g oral glucose tolerance test. Between 1994 and 1996, a 4.5-year follow-up study was undertaken and all previous participants were invited to reattend for a repeat oral glucose tolerance test. A total of 937 (87%) individuals were restudied (9) . Those who were not restudied on follow-up included individuals who refused to participate, had moved outside the U.K., or had died. Ethical permission for the study was received from the Cambridge Local Research Ethics Committee, and all participants provided written informed consent.
At both baseline and follow-up, individuals underwent a clinical examination, which included medical questionnaires and anthropometric measurements. BMI was calculated as weight in kilograms divided by height (in meters) squared. Waist circumference was measured at the midpoint between the inferior border of the coastal margin and the anterior superior iliac crest and hip circumference at the level of the greater trochanter. Diastolic and systolic blood pressure was recorded at rest, with the subject sitting, using an Accutorr automatic sphygmomanometer (Datascope, Cambridge, U.K.). The mean of three readings taken in the right arm (1 min apart) were analyzed in this study. In a health and lifestyle questionnaire, participants selfreported use of medicines.
The oral glucose tolerance test consisted of a 75-g oral glucose challenge with collection of venous blood samples at time 0 and 120 min. Plasma samples were immediately separated, kept on ice, and stored at Ϫ70°C within 4 h. Serum samples were separated after 30 min at room temperature and then stored at Ϫ70°C. Plasma glucose was measured by a hexokinase method (10), and triglyceride level was measured using the RA 1000 (Bayer Diagnostics, Basingstoke, U.K.), with a standard enzymatic method. Plasma insulin was determined by twosite immunometric assays with either 125 I or alkaline phosphatase labels (11, 12) .
Fasting insulin was used in the analysis as a marker of insulin resistance (13) .
Statistical methods
Arithmetic means and SEM are presented where the underlying variable was normally distributed. Triglycerides and insulin were normalized by logarithmic transformation and are presented as geometric mean and 95% CI. Unpaired Student's t tests were used to compare means between sexes, and paired Student's t tests were used to analyze the change between baseline and follow-up. The variables included in the principal component analysis (PCA) were the differences between baseline and follow-up results for the possible components of the syndrome. The relationship between individual pairs of variables was examined using Pearson correlation coefficients, separately for men and women. Bartlett's test of sphericity was used to test the hypothesis that the correlation matrix was an identity matrix in which all diagonal terms are 1 and all off-diagonal terms are 0. If a matrix is close to identity, this can indicate that the correlation between variables is too small to undertake factor analysis.
Factor extraction was performed using PCA to transform the correlated variables to a set of uncorrelated variables or factors by finding the linear combination to explain the maximum variance (14) . PCA does not place an a priori restriction on the number of factors. Each factor was characterized by its loading or correlation with the original variables, which, in this case, was the change over time of the components of the syndrome. Only factors with a variance or eigenvalue Ͼ1 were retained, because a factor with a variance Ͻ1 is no better than the individual variable. Orthogonal rotation using the varimax method was used to identify a unique set of closely related original variables for each factor. Factor loadings Ն0.25 were retained and may be interpreted as the contribution of that variable to the specific factor. All analyses were conducted using SPSS for Windows software (SPSS, Chicago, IL).
RESULTS -A total of 89% of the nondiabetic women initially recruited (543 of 608) and 85% of the nondiabetic men (394 of 463) underwent follow-up testing (9) . Of the individuals presenting both at baseline and at follow-up, 266 women and 200 men were either being treated with an antihypertensive and/or a lipidlowering drug at some stage during the study, and the analyses were repeated with these subjects excluded. The baseline characteristics and change over the 4.5 years of follow-up are shown in Table  1 . All of the change variables were normally distributed, even when single measures of the variable were non-normal. At baseline, BMI, WHR, blood pressure, and fasting plasma glucose, fasting insulin, triglyceride, and HDL cholesterol levels were higher in men (Table 1 ). In the whole population, the mean glucose, triglycerides, and blood pressure improved over the 4.5 years of follow-up, despite the cohort becoming older and, on average, more overweight. In the untreated subgroup, blood pressure increased on average.
Analysis of the correlation between changes in the metabolic parameters and change in BMI and WHR (Table 2) shows that increasing obesity was associated with increases in blood pressure, fasting insulin, glucose, and triglycerides and was negatively correlated with change in HDL cholesterol. Most of the changes in the components of the metabolic syndrome were correlated with each other, although minor differences existed between men and women. In general, the same pattern of associated change was observed in the whole cohort as in the untreated subgroup.
In the men and women, Bartlett's test of sphericity was significant ( 2 ϭ 387.8, P Ͻ 0.001 and 2 ϭ 541.6, P Ͻ 0.001, respectively) in the whole population and in the untreated sub-group ( 2 ϭ 335.8, P Ͻ 0.001 and 2 ϭ 329.7, P Ͻ 0.001, respectively). A large 2 value is a prerequisite for conducting PCA. Before rotation, the results of PCA indicated the presence of three independent factors in men and four in women. We performed rotation (Table 3) , and in untreated men, three independent factors explained 58.3% of the total variance. In untreated women, four factors explained 63.4% of the variance. In the untreated men, the first factor was characterized by positive correlation coefficients (loadings) with both systolic and diastolic blood pressure, the second could be characterized as being related to glucose metabolism, and the third was related to lipid metabolism. Changes in BMI, WHR, and fasting insulin were highly correlated with both the glucose and the lipid factors, and change in BMI alone was correlated with the blood pressure factor. In women, three factors related separately to blood pressure, lipid metabolism, and glucose metabolism, but changes in BMI, WHR, and fasting insulin were present as an additional independent factor. In the untreated women, change in BMI was correlated with change in the glucose factor and with the factor related to change in fasting insulin and triglyceride.
To examine the centrality of features to the various factors, we constructed three-dimensional loading plots separately for the untreated men and women ( Fig. 1A and B) . Each axis shows one of these factors, and the relationship to change in the features of the metabolic syndrome is represented by the factor loadings. The plots show that changes in BMI, WHR, and fasting insulin are central to the three independent factors in men, whereas change in BMI was central in women only. A similar observation was seen in the entire cohort (Fig. 1C) .
CONCLUSIONS -To our knowledge, this is the first report of a PCA of change in the features of the metabolic syndrome over time. The examination of the pattern of change in these related variables provides stronger evidence of the nature of the underlying biological relationships than previous cross-sectional studies, because clustering of variables in a prospective study indicates that they change in a correlated way. Our results suggest that the pattern of change in the components of the syndrome can be reduced to three uncorrelated sets of features in men and four in women. In both sexes, change in overall obesity, as measured by the BMI, is central to all factors. This provides support for the hypothesis that the different dimensions of the syndrome are linked through obesity.
Our longitudinal results are consistent with previous cross-sectional studies, including that by Meigs et al. (15) , which identified three identical factors among men. A separate study in older JapaneseAmerican subjects identified four factors in men, but the analysis did not include measurements of postglucose load. The additional factor detected in this study was characterized by positive correlations with body weight, waist circumference, and fasting insulin. Meigs et al. (15) also showed the same three factors in women as in men. However, using the same method to retain factors in the analysis of our longitudinal data, we identified an additional factor among women. A previous factor analysis in a sample of 277 women also found four similar factors (6) . An analysis conducted with our data only in women older than 50 years identified the same four factors, suggesting that menopausal status was not responsible for the difference between men and women.
The results in our study are similar, whether we considered the entire cohort or the subgroup of individuals who were not treated with antihypertensive medication or drugs for dyslipidemia. Because of the possibility that such drugs could alter the inter-relationships between change in the various features of the syndrome, we would tend to put more weight on the findings in the untreated subgroup. It is interesting to note that even in this group, there was an apparent overall improve- ment in fasting and 2-h glucose and triglyceride over the 4.5 years of follow-up despite an increase in mean BMI. Because the same laboratory measured these biochemical parameters throughout the study and had consistent quality control results, it is more likely that such changes represent either an alteration in health behavior as a consequence of observation (a Hawthorne effect) or a secular change in the determinants of glucose and lipid levels at the population level. However, the important observation from the perspective of this particular analysis is not the absolute change, but rather the pattern of the correlated change in the different dimensions of the syndrome, which clearly indicates the importance of obesity. Previous cross-sectional factor analysis studies have also suggested the centrality of obesity, as measured by the BMI, within the syndrome (3,6,7). Our longitudinal data show that change in BMI is central to the correlated change in the other features of the metabolic syndrome. Although our data also show that change in insulin levels and WHR are common to change in the other parameters, the strength of association is weaker than for BMI. Previously, Reaven (1) postulated that insulin resistance was the underlying defect of the syndrome, and in prospective studies, it has been shown that an increase in fasting insulin concentrations predicts the clustering of metabolic disorders (2). However, Liese et al. (5) showed in a cohort study that overall and central obesity and hyperinsulinemia were independently predictive of the metabolic syndrome and that there was evidence of a synergistic effect between them. Our data confirm the importance of obesity as the central component of the syndrome, an hypothesis supported by the effect of weight loss on insulin sensitivity (16) .
Because the metabolic syndrome is a combination of several features, which are themselves continuous variables, a dichotomous definition is probably not appropriate. Analysis of the syndrome using continuous variables, which is a feature of PCA, is probably more appropriate, because this method avoids choosing cutoff points for each component, which are still debated, especially for fasting insulin (17) . Choosing arbitrary cutoffs and reducing the syndrome to a binary state can also ignore some of the more subtle metabolic abnormalities (18) . In most previous studies, the syndrome has been defined with a minimum number (two or three) of features, with each weighted equally based on a dichotomous definition (2, 5) . However, the inclusion in some definitions (19) of a mixture of possible underlying factors (insulin resistance and obesity), along with those that may be secondarily related (hypertension or dyslipidemia), may prove to be a barrier to understanding pathophysiology.
Our analysis suggests that the metabolic syndrome could be characterized by three primary components: obesity (BMI), central obesity (WHR), and hyperinsulinemia (fasting insulin), which may be essential for the development of the syndrome; and three secondary components: hypertension, dyslipidemia (high triglycerides and low HDL cholesterol), and glucose intolerance (PG0 and PG120), which may be related to the central features. Such a proposal would need verification in other populations.
